First-Line Camizestrant for Emerging - The New England Journal of Medicine
31 May 2025 at 11:59pm
Mutations in ESR1 are the most common mechanism of acquired resistance to treatment with an aromatase inhibitor plus a cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor for advanced breast cancer....
A Crossover Trial of Hospital-Wide Lactated Ringer?s Solution versus ...
11 Jun 2025 at 11:53pm
Whether lactated Ringer?s solution is clinically superior to normal saline for routine intravenous administration of fluids is uncertain. In an open-label, two-period, two-sequence, cross ...
Survival of Transplanted Allogeneic Beta Cells with No ...
4 Aug 2025 at 4:58pm
The need to suppress a patient?s immune system after the transplantation of allogeneic cells is associated with wide-ranging side effects. We report the outcomes of transplantation of ...
Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis
4 Mar 2025 at 11:56pm
Bacterial vaginosis affects one third of reproductive-aged women, and recurrence is common. Evidence of sexual exchange of bacterial vaginosis?associated organisms between partners suggests that ...
Lorundrostat Efficacy and Safety in Patients with Uncontrolled ...
22 Apr 2025 at 11:55pm
Aldosterone dysregulation contributes to hypertension. Lorundrostat is an aldosterone synthase inhibitor, but data on its efficacy and safety in patients with hypertension are limited. In this mult...
Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
31 May 2025 at 11:59pm
In this phase 3, randomized trial conducted at 55 centers, we assigned patients with resected colon cancer who had completed adjuvant chemotherapy to participate in a structured exercise program ...
Clinical Practice Topics | The New England Journal of Medicine
22 Apr 2026 at 5:08am
Recognizing Historical Injustices in Medicine and the Journal Tobacco Use Reduction Additional Topics A Accountable Care Organizations Acute Coronary Syndromes Acute Kidney Injury Addiction
Zongertinib in Previously Treated - The New England Journal of Medicine
28 Apr 2025 at 1:46pm
Innovative oral targeted therapies are warranted for patients with human epidermal growth factor receptor 2 (HER2)?mutant non?small-cell lung cancer (NSCLC). Zongertinib is an oral ...
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
8 Apr 2025 at 11:14pm
Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called disability accrual. Current disease-modifying therapies for multiple sclero...
Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous ...
21 Jun 2025 at 11:55pm
In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to fasting blood glucose levels. A fixed-dose regimen of insulin efsitora alfa...
WHAT IS THIS? This is an unscreened compilation of results from several search engines. The sites listed are not necessarily recommended by Surfnetkids.com.
31 May 2025 at 11:59pm
Mutations in ESR1 are the most common mechanism of acquired resistance to treatment with an aromatase inhibitor plus a cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor for advanced breast cancer....
A Crossover Trial of Hospital-Wide Lactated Ringer?s Solution versus ...
11 Jun 2025 at 11:53pm
Whether lactated Ringer?s solution is clinically superior to normal saline for routine intravenous administration of fluids is uncertain. In an open-label, two-period, two-sequence, cross ...
Survival of Transplanted Allogeneic Beta Cells with No ...
4 Aug 2025 at 4:58pm
The need to suppress a patient?s immune system after the transplantation of allogeneic cells is associated with wide-ranging side effects. We report the outcomes of transplantation of ...
Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis
4 Mar 2025 at 11:56pm
Bacterial vaginosis affects one third of reproductive-aged women, and recurrence is common. Evidence of sexual exchange of bacterial vaginosis?associated organisms between partners suggests that ...
Lorundrostat Efficacy and Safety in Patients with Uncontrolled ...
22 Apr 2025 at 11:55pm
Aldosterone dysregulation contributes to hypertension. Lorundrostat is an aldosterone synthase inhibitor, but data on its efficacy and safety in patients with hypertension are limited. In this mult...
Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
31 May 2025 at 11:59pm
In this phase 3, randomized trial conducted at 55 centers, we assigned patients with resected colon cancer who had completed adjuvant chemotherapy to participate in a structured exercise program ...
Clinical Practice Topics | The New England Journal of Medicine
22 Apr 2026 at 5:08am
Recognizing Historical Injustices in Medicine and the Journal Tobacco Use Reduction Additional Topics A Accountable Care Organizations Acute Coronary Syndromes Acute Kidney Injury Addiction
Zongertinib in Previously Treated - The New England Journal of Medicine
28 Apr 2025 at 1:46pm
Innovative oral targeted therapies are warranted for patients with human epidermal growth factor receptor 2 (HER2)?mutant non?small-cell lung cancer (NSCLC). Zongertinib is an oral ...
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
8 Apr 2025 at 11:14pm
Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called disability accrual. Current disease-modifying therapies for multiple sclero...
Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous ...
21 Jun 2025 at 11:55pm
In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to fasting blood glucose levels. A fixed-dose regimen of insulin efsitora alfa...
WHAT IS THIS? This is an unscreened compilation of results from several search engines. The sites listed are not necessarily recommended by Surfnetkids.com.
